SEC Form D filing

BioCytics, Inc., 2026-03-13

An SEC Form D private-offering notice from Huntersville, NC, a $7,000,000 filer-stated offering target in Biotech. Filed 2026-03-13. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

BioCytics, Inc. site↗ Verified via SEC Form D

Biotechnology company developing autologous adaptive cell therapy, an immuno-oncology platform using a patient's own immune cells to treat solid tumors.

Filed 2026-03-13Filed to raise $7,000,000First money in 2026-01-02Raised so far $25,000HQ (as filed) Huntersville, NCSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified biocytics.com↗Named in the filing 2 executives & directors
Open this row on the live feed →More new filings in North Carolina →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source